Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis
Allergic rhinitis/rhinosinusitis (AR) is the most common allergic disease. It affects patients’ quality of life and may influence the severity of lower airway disease such as asthma. Therefore, its treatment is of great importance. AR is treated by a combination of effective approaches; however, in...
Main Authors: | Viera Janosova, Vladimir Calkovsky, Heiko Pedan, Estera Behanova, Andrej Hajtman, Andrea Calkovska |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01135/full |
Similar Items
-
The prevalence of rhinosinusitis in allergic rhinitis
by: V Kirtsreesakul
Published: (2006-08-01) -
The Role of the Level of Interleukin-33 in the Therapeutic Outcomes of Immunotherapy in Patients with Allergic Rhinitis
by: Wail Fayez Nasr, et al.
Published: (2018-04-01) -
Allergic rhinitis and the phenomenon of entopy
by: A. V. Klimov, et al.
Published: (2020-10-01) -
IV Brazilian Consensus on Rhinitis - an update on allergic rhinitis,
by: Eulalia Sakano, et al. -
Allergic rhinitis
by: S. V. Ryazantsev, et al.
Published: (2018-11-01)